Even within a few weeks of starting on Control-IQ by Tandem Diabetes Care, I knew that this new system that helps automate insulin dosing was the right choice and could help me better manage my ...
GlobalData on MSN
Tandem secures FDA approval for Control-IQ+ use in pregnancy
The approval is based on findings from the CIRCUIT trial published in JAMA in October 2025.
Ballston Spa, New York–August 28, 2007–ReQuest, Inc., the innovator that leads the custom-installation music-server market, has added a double handful of valuable new features to its groundbreaking iQ ...
A new artificial pancreas system, called Control-IQ, has helped people with type 1 diabetes to spend more time in their target glucose range, according to a newly published study. An artificial ...
An artificial pancreas developed at the University of Virginia Center for Diabetes Technology improves blood sugar control for people ages 2 to 72 with type 1 diabetes, according to a new combined ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of ...
Officials in America have approved a system, called Control-IQ, for closed-loop insulin delivery for people with type 1 diabetes. The Control-IQ technology by Tandem Diabetes Care can be used with ...
The U.S. Food and Drug Administration has approved an artificial pancreas system - based on technology from the University of Virginia Center for Diabetes Technology - that automatically monitors and ...
WEST PALM BEACH, Fla., Nov. 15, 2021 (GLOBE NEWSWIRE) -- GeoArm, a pioneer in the DIY security market, has released the much anticipated Qolsys IQ Panel 4 wireless touchscreen alarm controller. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results